Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch

Active Ingredient:
norelgestromin, ethinylestradiol
Company:  
Gedeon Richter (UK) Ltd See contact details
ATC code: 
G03AA13
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Annex 2 CHC Prescriber Checklist

{healthcare_pro_orange} For Healthcare Professionals

Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations.

{pdf_link}

Annex 3 CHC User Card

Important Information for Women - Summary of risk of blood clots with combined hormonal contraception.

{pdf_link}

Annex 4 Important Information for Women

Leaflet with information on combined oral contraception to be given to the patient by the physician.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Gedeon Richter (UK) Ltd
Company image
Address
127 Shirland Road, London, W9 2EP, UK
WWW
http://www.gedeonrichter.co.uk
Telephone
+44(0)207 604 8800
E-mail
[email protected]
Medical Information Direct Line
+44 (0)207 604 8806
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)207 604 8800
Medical Information Fax